Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
5.02
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
5.01
-0.01 (-0.30%)
After-hours: Dec 5, 2025, 4:10 PM EST
Precision BioSciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Revenue | 0.7 | 68.7 | 48.73 | 25.1 | 115.53 | 24.29 | Upgrade
|
| Revenue Growth (YoY) | -99.07% | 40.98% | 94.15% | -78.28% | 375.72% | 9.21% | Upgrade
|
| Gross Profit | 0.7 | 68.7 | 48.73 | 25.1 | 115.53 | 24.29 | Upgrade
|
| Selling, General & Admin | 34.43 | 35.3 | 39.09 | 43.34 | 43.23 | 39.41 | Upgrade
|
| Research & Development | 55.77 | 59.56 | 53.38 | 44.07 | 111.68 | 94.71 | Upgrade
|
| Operating Expenses | 90.2 | 94.86 | 92.46 | 87.41 | 154.91 | 134.11 | Upgrade
|
| Operating Income | -89.5 | -26.16 | -43.74 | -62.31 | -39.38 | -109.83 | Upgrade
|
| Interest Expense | -1.47 | -1.78 | -2.23 | -1.11 | -0.13 | - | Upgrade
|
| Interest & Investment Income | 4.96 | 6.76 | 7.69 | 3.47 | 0.21 | 0.82 | Upgrade
|
| Earnings From Equity Investments | -0.89 | -1.08 | -4.93 | -1.58 | 0.18 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 6.58 | 29.61 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -80.31 | 7.35 | -43.21 | -61.53 | -39.12 | -109.01 | Upgrade
|
| Gain (Loss) on Sale of Investments | -3.08 | 0.26 | 1.15 | -0.51 | 2.56 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.21 | -0.44 | -0.46 | -0.03 | 5.96 | - | Upgrade
|
| Asset Writedown | - | - | - | -10.84 | - | - | Upgrade
|
| Pretax Income | -83.6 | 7.17 | -42.53 | -72.91 | -30.6 | -109.01 | Upgrade
|
| Earnings From Continuing Operations | -83.6 | 7.17 | -42.53 | -72.91 | -30.6 | -109.01 | Upgrade
|
| Earnings From Discontinued Operations | - | - | -18.79 | -38.73 | - | - | Upgrade
|
| Net Income | -83.6 | 7.17 | -61.32 | -111.64 | -30.6 | -109.01 | Upgrade
|
| Net Income to Common | -83.6 | 7.17 | -61.32 | -111.64 | -30.6 | -109.01 | Upgrade
|
| Shares Outstanding (Basic) | 10 | 7 | 4 | 3 | 2 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 7 | 4 | 3 | 2 | 2 | Upgrade
|
| Shares Change (YoY) | 68.98% | 79.20% | 31.11% | 49.77% | 12.79% | 23.91% | Upgrade
|
| EPS (Basic) | -8.32 | 1.05 | -15.96 | -38.10 | -15.64 | -62.85 | Upgrade
|
| EPS (Diluted) | -8.32 | 1.04 | -15.96 | -38.10 | -15.64 | -62.85 | Upgrade
|
| Free Cash Flow | -73.44 | -58.7 | -86.07 | -49.07 | -15.91 | -92.42 | Upgrade
|
| Free Cash Flow Per Share | -7.31 | -8.53 | -22.41 | -16.75 | -8.13 | -53.28 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -12822.64% | -38.08% | -89.76% | -248.26% | -34.08% | -452.25% | Upgrade
|
| Profit Margin | -11977.36% | 10.43% | -125.84% | -444.80% | -26.49% | -448.86% | Upgrade
|
| Free Cash Flow Margin | -10521.35% | -85.44% | -176.64% | -195.52% | -13.77% | -380.55% | Upgrade
|
| EBITDA | -87.93 | -22.76 | -36.92 | -54.51 | -30.4 | -101.05 | Upgrade
|
| EBITDA Margin | - | -33.13% | -75.77% | -217.19% | -26.31% | - | Upgrade
|
| D&A For EBITDA | 1.58 | 3.4 | 6.82 | 7.8 | 8.98 | 8.78 | Upgrade
|
| EBIT | -89.5 | -26.16 | -43.74 | -62.31 | -39.38 | -109.83 | Upgrade
|
| EBIT Margin | - | -38.08% | -89.76% | -248.26% | -34.08% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.